Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Lovastatin reduces expression of ER-alpha in human breast cancer cell lines

March 29, 2004

INDs filed for topical PEP-005

March 26, 2004

New European phase II/III trial for Bexidem in bladder cancer

March 26, 2004

Pamorelin LA receives approval in Germany

March 26, 2004

New tyrosine kinase inhibitors emerge from Merck R&D

March 26, 2004

Novartis and Scripps jointly describe new antitumor epothilones

March 26, 2004

Pfizer describes new CDK2/CDK4 inhibitors with utility in cancer therapy

March 26, 2004

Protective effects of palifermin during chemotherapy/radiotherapy

March 26, 2004

Astex Technology joins BRAF drug discovery collaboration

March 25, 2004

Aplidin enters phase I for pediatric solid tumors and hematological malignancies

March 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026